trial · primary record
IMVT-1402
Graves' Disease
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 210 |
| Primary completion | 2027-05 |
| Primary endpoint | Percentage of participants who are euthyroid and off ATD at Week 26 (Dose 1) |
| Registry ID | NCT07018323 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:41:35.469Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07018323
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.